394 related articles for article (PubMed ID: 17110303)
1. Low-grade dysplasia in Barrett's esophagus.
Odze RD; Goldblum JR
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
[No Abstract] [Full Text] [Related]
2. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
O'Connor JB; Falk GW; Richter JE
Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
[TBL] [Abstract][Full Text] [Related]
3. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
5. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro.
Wani S; Choi W; Sharma P
Endoscopy; 2007 Jul; 39(7):643-6. PubMed ID: 17611920
[No Abstract] [Full Text] [Related]
6. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Contra.
Vieth M
Endoscopy; 2007 Jul; 39(7):647-9. PubMed ID: 17611921
[No Abstract] [Full Text] [Related]
7. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
[TBL] [Abstract][Full Text] [Related]
8. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
Donnellan F; Harewood GC; Patchett SE
Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
[No Abstract] [Full Text] [Related]
9. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus and cancer risk: a more realistic estimate.
Rajendra S; Sharma P
Semin Thorac Cardiovasc Surg; 2011; 23(4):261-2. PubMed ID: 22443641
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
12. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery.
von Conrady D; Smith MJ; Khan MF; Tan S; Mortimer G; McAnena OJ
Endoscopy; 2008 Sep; 40 Suppl 2():E68-9. PubMed ID: 18633915
[No Abstract] [Full Text] [Related]
13. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
14. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR
Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
[TBL] [Abstract][Full Text] [Related]
15. Barrett's: do we still need goblet cells for diagnosis?
Lenglinger J; Riegler M
Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
[No Abstract] [Full Text] [Related]
16. Management of Barrett's esophagus: cases and questions.
Bresalier R
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
[TBL] [Abstract][Full Text] [Related]
17. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
Curvers WL; ten Kate FJ; Krishnadath KK; Visser M; Elzer B; Baak LC; Bohmer C; Mallant-Hent RC; van Oijen A; Naber AH; Scholten P; Busch OR; Blaauwgeers HG; Meijer GA; Bergman JJ
Am J Gastroenterol; 2010 Jul; 105(7):1523-30. PubMed ID: 20461069
[TBL] [Abstract][Full Text] [Related]
18. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic findings and treatment of a recurrent adenocarcinoma with a submucosal tumor-like appearance in short-segment Barrett's esophagus.
Yagi K; Aruga Y; Nakamura A; Sekine A
Endoscopy; 2006 Feb; 38(2):198. PubMed ID: 16479433
[No Abstract] [Full Text] [Related]
20. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology.
Chen Y; Aguirre AD; Hsiung PL; Desai S; Herz PR; Pedrosa M; Huang Q; Figueiredo M; Huang SW; Koski A; Schmitt JM; Fujimoto JG; Mashimo H
Endoscopy; 2007 Jul; 39(7):599-605. PubMed ID: 17611914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
